Pyrrolotriazinone and imidazotriazinone derivatives as ubiquitin-specific protease inhibitors No. 7 (USP7) for the treatment of cancer

MA41291AUndetermined Publication Date: 2017-11-07FORMA THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA41291
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-12-30
Filing Date: 2015-12-28
Publication Date: 2017-11-07

Application Information

Patent Timeline

30 Dec 2014

Priority

28 Dec 2015

Application

MA41291

07 Nov 2017

Publication

MA41291A

IPC: A61K31/53; A61P9/00; A61P9/10; A61P25/28; A61P31/04; A61P31/12; A61P35/00; A61P37/00; C07D487/04

CPC: C07D487/04; A61P1/04; A61P13/12; A61P19/02; A61P19/08; A61P19/10; A61P21/02; A61P25/00

Inventors: BUCKMELTER Alexandre Joseph; CAMPBELL Ann-Marie

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.